Persistent pulmonary hypertension of the newborn after fetomaternal hemorrhage

Abstract

BACKGROUND: Newborns with anemia are at increased risk of persistent pulmonary hypertension of the newborn (PPHN), yet reports on the association between fetomaternal hemorrhage (FMH) and PPHN are rare. To optimize care for pregnancies complicated by FMH, clinicians should be aware of the risks of FMH and the possible diagnostic and therapeutic options. To increase the current knowledge, the incidence of PPHN and short-term neurologic injury in FMH cases were studied. STUDY DESIGN AND METHODS:We included all FMH cases (≥30 mL fetal blood transfused into the maternal circulation) admitted to our neonatal unit between 2006 and 2018. First, we evaluated the incidence of PPHN and short-term neurologic injury. Second, we studied the potential effect of intrauterine transfusion (IUT).RESULTS: PPHN occurred in 37.9% of newborns (11 of 29), respectively, 14.3% (one of seven) and 45.5% (10 of 22) in the IUT group and no-IUT group (p = 0.20). The mortality rate was 13.8% (4 of 29). Severe brain injury occurred in 34.5% (10 of 29), respectively, and 14.3% (one of seven) and 40.9% (nine of 22) in the IUT group and no-IUT group (p = 0.37). ABBREVIATIONS: CTG = cardiotocogram; FMH = fetomaternal hemorrhage; IUT = intrauterine transfusion; LUMC = Leiden University Medical Center; PPHN = persistent pulmonary hypertension of the newborn. From the

Hydrops Fetalis and Persistent Pulmonary Hypertension in a Neonate with Anti-E Alloimmunization

“…A few case reports have described the association of congenital anemia with development of PPHN [15, 16]. Congenital anemia leads to systemic hypoxemia, which in turn may exacerbate pulmonary vascular resistance [17].…”

Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn

“…** Shows a potential trigger for referral to the fetal medicine center. quences of the persisting maternal antibody [54] present in the newborn. In most cases the fetal RBCs will carry maternal antibodies detectable by the DAT.…”